| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,156,000 | 7,088,000 | 7,270,000 | 6,070,000 | | Cost of Revenue | 4,560,000 | 5,007,000 | 5,185,000 | 5,785,000 | | | Gross Profit | 1,596,000 | 2,081,000 | 2,085,000 | 285,000 | | | Operating Expenses | | Research Development | 335,000 | 331,000 | 323,000 | 343,000 | | Selling General and Administrative | 770,000 | 907,000 | 907,000 | 799,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 491,000 | 843,000 | 855,000 | (857,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (265,000) |
-
|
-
| | Earnings Before Interest And Taxes | 491,000 | 578,000 | 855,000 | (857,000) | | Interest Expense | 100,000 | 106,000 | 106,000 | 104,000 | | Income Before Tax | 391,000 | 472,000 | 749,000 | (961,000) | | Income Tax Expense | (23,000) | 51,000 | 260,000 | (325,000) | | Minority Interest | (5,000) | (4,000) | (1,000) | 7,000 | | | | Net Income From Continuing Ops | 409,000 | 417,000 | 488,000 | (629,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 409,000 | 417,000 | 488,000 | (629,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $409,000 | $417,000 | $488,000 | ($629,000) |
|
1.29% Nasdaq 
Income Statement
